Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (26 ops.)
Latest filing published 05 Sept 2024 for Aadi Bioscience, Inc., €62k. Read the official filing
Filing timeline
BuySaleNeil Desai
Insider track record
Disclosed buys
0
Disclosed sells
26
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Neil Desai: trading record in brief
Neil Desai discloses dealings in Whitehawk Therapeutics, Inc. to SEC (Form 4). In total, 26 filings cover trades dated from 18 March 2022 to 3 September 2024.
The open-market record consists of 26 sales worth €1.6M, with no purchase. In 2024 alone, the filings show no purchases and 10 sales.
The newest entry dates from 5 September 2024: an open-market sale of €62k, in Whitehawk Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Neil Desai
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
40,000 shares@ US$1.70794.0% of flowCommon StockSEC:0001415889-24-022964:0
15,415 shares@ US$1.49561.4% of flowCommon StockSEC:0001415889-24-020784:0
31,348 shares@ US$1.45482.7% of flowCommon StockSEC:0001415889-24-019045:0
8,652 shares@ US$1.34210.7% of flowCommon StockSEC:0001415889-24-019045:1
19,775 shares@ US$1.80862.1% of flowCommon StockSEC:0001415889-24-015561:0
40,000 shares@ US$1.92964.6% of flowCommon StockSEC:0001415889-24-011937:0
17,772 shares@ US$2.31272.5% of flowCommon StockSEC:0001415889-24-010037:0
27,036 shares@ US$1.96873.2% of flowCommon StockSEC:0001415889-24-006421:0
42,000 shares@ US$1.74454.4% of flowCommon StockSEC:0001209191-24-002684:0
42,000 shares@ US$2.06075.0% of flowCommon StockSEC:0001209191-24-000254:0
7,037 shares@ US$4.81942.0% of flowCommon StockSEC:0001209191-23-057713:0
8,347 shares@ US$5.13732.5% of flowCommon StockSEC:0001209191-23-057545:0
10,876 shares@ US$5.14773.3% of flowCommon StockSEC:0001209191-23-057545:1
15,740 shares@ US$5.01534.7% of flowCommon StockSEC:0001209191-23-057545:2
10,338 shares@ US$4.31852.7% of flowCommon StockSEC:0001209191-23-054214:0
25,569 shares@ US$4.36856.9% of flowCommon StockSEC:0001209191-23-051697:0
13,889 shares@ US$5.96684.9% of flowCommon StockSEC:0001209191-23-048535:0
22,710 shares@ US$5.2196.9% of flowCommon StockSEC:0001209191-23-044439:0
10,000 shares@ US$6.64463.9% of flowCommon StockSEC:0001209191-23-041700:0
7,260 shares@ US$8.18913.6% of flowCommon StockSEC:0001209191-23-034888:0
4,982 shares@ US$7.92222.4% of flowCommon StockSEC:0001209191-23-034632:0
2,305 shares@ US$7.56821.0% of flowCommon StockSEC:0001209191-23-027672:0
24,479 shares@ US$7.798311.2% of flowCommon StockSEC:0001209191-23-027161:0
12,212 shares@ US$7.09275.1% of flowCommon StockSEC:0001209191-23-023692:0
9,583 shares@ US$7.4464.2% of flowCommon StockSEC:0001209191-23-023483:0
25 of 26 declarations
